Lilly and subsidiary Point Biopharma accused of patent infringement of cancer drugs

Please subscribe to IBJ to decode this article.

iL e neaee batdrdcb Fno ayg rhcpraecnonRh oilrut tontiyutE sa tt ed rePo arsiienaCyngda b e ufra.lpsrautep omhol a uiglhiaea ccconehn fthmod.atnd inyt la

icawyloTaais ni n.r ilyipadeonf fae aea tiNhmopemtvu niedcsiLoUfaad enalrcn azSCur dt tSspt ssloif.Tatt -armuroo.cfnn tosc.rhedsa ICafrafhleienPmr iyrDEc ea.its e r nucdadnehocn.ptCotoot

/pb as oarm/ehthgaNfn pbsn ombrPd4atm ncmsuf-da-t 1seloe i "a"d-siyyoaipc a:eaciLgraclhn/Ldlogo eIt1.adae olylosasor-t,o wsoli atsudi.rbwii"rtp>-raenap ttfyreisrcioreadmlpa-iee=lan hbrnfBg

h n 2,eabingnadgtndslA nai s aerieo sngeeimud ndnrs0s linusvwBoItadpiaoa p eoosri yiudsd ae i2 huei tnhspri P 0buta ed.dfte epnoidaPr,et

co pomaTtn aetnrvretmssai hce pohaelgrlce iosgcct edtalra n ntc ocameuirwa esualddaseriaudg oiipra.

reax ig e Ir vfnrp nanuamgi oeealieedloi ktti n pnr damtabeihtntrpcdrhmemad ess rne v.leeesosd trr.c ocdit andaac cn rcr o eeirgrews ggiinacssr to nheegnnettTiatcrnteorsetuli rttd cea o crdll o eaniuo cgbslsyw itnl f vrt o dohce, tgTrao fip itoe r hiotihhrtlcno scyes o wehtyt eisl nakiasalvahiaiMatu owe eyeallaneao cnaanget au opshufenhfy ep.aaars t dlp o ae

ogsoaxpn tPgfsaurr la eh tsetmetd nstot t weni opoaatAtr focdtfeus ntocllhn ftnnenet o mrpi cnhhhplPucol ahd e’erinr tpl.mhsi,eestntitgn raapeic dracie e et ea ucs ftoeiair

nt iAloJlkea nhfetngdmieyeoteotlBLasIotess lrla :ew sm p

doeaaneaei aeBnBtl. au ichacorctripdgimathhIPGPnki aanos dtsncinesrpdrr pFeofentrundo" ilwiee oNLeiid f aaErieainraetvaipe lprOlTlemlcm d eo nioeryydau lenarWtRe,NntoInlo’tonslfhacdnmgtatdar ,t wtiwbna onupgevn tokoo t lt fNer Ptmsho eouI tnrter haatliroii i sopnt mdne n .moscs.da cfvtteg"dutynsss c wsi,td aemecs s.aaenP o a ueotalt nuOu asaeTrv,aatocre

ePlhyaubno6nyaLtv, d.fod.whyo Knu rorrne e-ngrS, wwndevrhe9E co rote, etovhlihu a ebt rn.atraou Die on iar9i i dun o nsy c,ue ee da d snmUeiaoh rptapitLtnat omi u ct tno1phdo-d lfPfeDsnotnciaien fmypbb sic

fdnhuho til tntiee rcpi“dern attr hovnt ie oftmtccnrhv.tenueEpon”ahosdnaslinr ay, aeoidv, atzse seo rhatcoeoena ionyovteg aeT t rm

nyd tp bat uelyNs rlemn1a dchh tdnEPhuepnwntaeuse ucor-tc e’inee evaral ipcsnai tiooaecPr.rloi t i0pela uird rvl2tnum,ec ttnaeludwi8tl r ghpstdSIdawceswnd h q’ibd aene e,uf oucuoao Na mr osesnisheddctetymsok mtnbrc.iv a,s evtaisas,tysinauratoyEcnr

dogn s uboci t i voi.o hNPsmt encE le tnyts pearCoNitasnayhlttsv,udxt lya cseeehaehrpenicrn

.2easeseN rudlo uoh.p0nuldt mat0m PtNh 2 ani a2i2Po ,r2iechorTdntteett ofl omfiNe ero eezwituiiohenued iasssueu0hns2ftt cr,L0 eeaIadiioe l,aboev i dtindepLishtsf2mterixnmo w rygsrgs n leg mm s0p Pn racoesoTnn ,tctnc Pe

m0sf rng tihi aeUke/ift lnn n tlngeoyeh lfnrg  hTktjpgafr,ftloana i2odTsts p tdr iPS taefpsro a re i s 0ntP N leafon o.gal nsl ainiaei igsf gefoogasna u2 admPae utpfaaogltoss en oskebnlteetmsgr0,tietmian0dey.iaesrTiitrfennaliyan rinNeot teno2h2npdtnTn nn, gi ice ir,dnPj hfds niriisn iro

n r sauTRah.dJneg e su gdcwdtg osaehiY oaseic